2022-02-01

Midas' API "Crotamiton" has been successfully approved in China

Midas is currently supplying the only imported Crotamiton API approved in China and meantime with a CEP certificate. Its registration status in the CDE (CENTER FOR DRUG EVALUATION) has been shown as "A (Active)". Customers who need to use Crotamiton as a raw material for R&D and production can use it with confidence.

Use of Crotamiton:

Crotamiton acts on the nervous system of scabies and kills it. In addition, it has a mild local anesthetic effect that relieves itching. It can be used as raw material or excipients in the pharmaceutical industry. The main dosage forms are among others creams and gel patches.

For more details, please contact us.

 

 

Your Contact

Thorsten Schäfer

Thorsten Schäfer

International Division
Chairman

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany
Send E-Mail

Share this page